The Brain Metabolism of Unpredictable Signals

Sponsor
Massachusetts General Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05756335
Collaborator
(none)
30
1
1
24
1.3

Study Details

Study Description

Brief Summary

The investigators will be studying brain glucose and oxygen metabolism using hybrid PET/fMRI imaging to better understand how decoupling between brain glucose and oxygen metabolism relates to the processing of unpredictable sensory signals.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: (Un)predictable and (un)attended stimuli
N/A

Detailed Description

The proposed research consists of one experiment, combining positron emission tomography (PET) and magnetic resonance imaging (MRI) techniques to simultaneously estimate the cerebral metabolic rates of glucose (CMRglc) and oxygen (CMRO2), and their ratio (oxygen:glucose index; OGI). These outcome measures will be collected in the context of a behavioral intervention presenting subjects with predictable and unpredictable stimuli, and attended and unattended stimuli. Functional PET uses a slow infusion of 2-[18F]-fluro-deoxyglucose (FDG) to estimate regional CMRglc, measuring relative changes in radiotracer uptake between blocks of task and rest. Dual-calibrated fMRI uses a sequence of hyperoxic (increased O2) and hypercapnic (increased CO2) challenges, along with a specialized sequence of MRI scans (estimating cerebral blood flow and blood-oxygen level-dependent signal) to estimate absolute CMRO2.

All subjects will be scanned, and each will complete the same behavioral intervention. First, the investigators will aim to assess the reliability of this hybrid imaging technique by having subjects complete two identical scan sessions. Second, the investigators will deliver a behavioral intervention to test the relationship between stimuli predictability, CMRglc, CMRO2, and OGI.

This experimental design is capable of producing effects observable in single subjects, and prior studies using fPET and dual-calibrated fMRI have produced effect sizes that our sample size is more than adequate to detect.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Quantifying the Brain Metabolism Underlying Task-Based BOLD Imaging
Anticipated Study Start Date :
Mar 1, 2023
Anticipated Primary Completion Date :
Feb 28, 2024
Anticipated Study Completion Date :
Feb 28, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Behavioral intervention

Subjects are presented with a simultaneous sequence of faces and spoken words. Face stimuli include a representative sample of realistic faces across a range of ages. Spoken word stimuli are simple nouns spoken by a single female speaker.

Behavioral: (Un)predictable and (un)attended stimuli
Subjects will complete four task conditions in each scan session: (1) Visual Unpredictable, (2) Visual Predictable, (3) Auditory Unpredictable, and (4) Auditory Predictable. In visual and auditory conditions subjects attend to visual or auditory stimuli and ignore the other domain, pressing a button when they detect an infrequently occurring stimulus inversion in the target domain. In unpredictable and predictable conditions, the attended domain either presents random (unpredictable) stimuli, or the same face or word stimuli repeated (predictable).

Outcome Measures

Primary Outcome Measures

  1. Brain positron emission tomography (PET) imaging signals [after PET image analysis and with study completion, an average of 1 year]

    Changes in glucose metabolism will be quantified from brain PET images

  2. Functional magnetic resonance imaging (fMRI) signals [after fMRI image analysis and with study completion, an average of 1 year]

    Changes in oxygen metabolism will be quantified from dual-calibrated fMRI

  3. Oxygen-glucose index [after PET/fMRI image analysis and with study completion, an average of 1 year]

    Ratio of cerebral metabolic rates of glucose and oxygen from PET and fMRI signals

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 35 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Adults aged 21-35.

  • No contraindications to MRI or PET scanning.

  • Right-handed.

  • Fluent to speak, read, and understand English.

Exclusion Criteria:
  • Adults unable to consent

  • Contraindications to fMRI scanning and PET scanning (including the presence of a cardiac pacemaker or pacemaker wires, metallic particles in the body, vascular clips in the head or previous neurosurgery, prosthetic heart valves, claustrophobia)

  • Inability to lie motionless in the scanner

  • Pregnancy, seeking or suspecting pregnancy, or breastfeeding

  • History of major head trauma

  • Intracranial lesion

  • Cardiovascular disorders, including heart disorders or high blood pressure [>155/95]

  • Breathing problems such as severe asthma, emphysema, or pulmonary disease

  • Bleeding disorder, or use of anticoagulants

  • Bladder obstruction, urinary problems, or history of impaired elimination

  • Known kidney or liver problems

  • Past severe COVID-19 infection

  • Intestinal blockage

  • Raynaud syndrome

  • Anemia

  • Peripheral nerve injury

  • Diabetes

  • Glaucoma

  • Current or recent use of medications (neurological or psychiatric) affecting brain function

  • Current or past history of major medical, neurological, or psychiatric condition

  • Current or past history of chronic pain (assessed at the discretion of PI)

  • Current smoker

  • Body mass index above 35

  • Research-related radiation exposure exceeds current Radiology Department guidelines

  • Lack of current health insurance coverage

  • Employed under the direct supervision of the investigators conducting the research

  • Unwilling or unable to cooperate with breathing maneuvers required during the gas challenge

  • Respiratory or cardiac limitations to breathing at 20 L/min

Contacts and Locations

Locations

Site City State Country Postal Code
1 Athinoula A. Martinos Center for Biomedical Imaging Charlestown Massachusetts United States 02129

Sponsors and Collaborators

  • Massachusetts General Hospital

Investigators

  • Principal Investigator: Christin Y Sander, PhD, Athinoula A. Martinos Center for Biomedical Imaging

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Christin Y. Sander, PhD, Assistant Professor, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT05756335
Other Study ID Numbers:
  • 2022P002851
First Posted:
Mar 6, 2023
Last Update Posted:
Mar 6, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Christin Y. Sander, PhD, Assistant Professor, Massachusetts General Hospital

Study Results

No Results Posted as of Mar 6, 2023